Christopher I. Wright

Insider Reports History

Entity
Individual
Location
C/O Cyclerion Therapeutics, Inc., 245 First Street, 18 Th Floor, Cambridge, MA
Signature
/s/ Shantale Greenson, attorney-in-fact for Christopher I. Wright
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christopher I. Wright:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Alkermes plc. Director Non Qualified Stock Option (Right to Buy) 17.5K $537K $30.72 May 31, 2024 Direct
Alkermes plc. Director Ordinary Shares 14.4K $347K $24.10 Jun 29, 2024 Direct
Alkermes plc. Director Restricted Stock Unit Award 0 Jun 29, 2024 Direct

Insider Reports Filed by Christopher I. Wright

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ALKS Alkermes plc. Jun 29, 2024 3 -$35.3K 4 Jul 1, 2024 Director
ALKS Alkermes plc. Jun 8, 2024 3 -$19K 4 Jun 10, 2024 Director
ALKS Alkermes plc. May 31, 2024 8 $25.4K 4 Jun 4, 2024 Director
ALKS Alkermes plc. Jul 7, 2023 3 -$42.7K 4 Jul 10, 2023 Director
ALKS Alkermes plc. Jun 29, 2023 2 $0 4 Jun 30, 2023 Director
ALKS Alkermes plc. Jun 8, 2023 6 -$27.3K 4 Jun 12, 2023 Director
ALKS Alkermes plc. Jul 7, 2022 2 $0 4 Jul 8, 2022 Director
ALKS Alkermes plc. Jun 8, 2022 4 $0 4 Jun 10, 2022 Director
ALKS Alkermes plc. May 24, 2022 0 $0 3 May 31, 2022 Director